Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865325/0/en/Monopar-Announces-Radiopharma-Presentation-Selected-for-Society-of-Nuclear-Medicine-and-Molecular-Imaging-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/16/2863563/0/en/Monopar-Announces-Filing-of-Patent-Protecting-MNPR-101-Radiopharma-Optimization-Findings.html
https://www.globenewswire.com/news-release/2024/04/10/2860708/0/en/Monopar-Initiates-Radiopharma-Phase-1-Clinical-Trial-for-MNPR-101-Zr-in-Advanced-Cancer-Patients.html
https://www.globenewswire.com/news-release/2024/03/28/2853844/0/en/Monopar-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Developments.html
https://www.globenewswire.com//news-release/2024/03/05/2840264/0/en/Monopar-Announces-Positive-Preclinical-Therapeutic-Isotope-Data-for-its-MNPR-101-Radiopharma-Program.html
https://www.globenewswire.com//news-release/2024/02/27/2835853/0/en/Monopar-Provides-Update-on-MNPR-101-Zr-Radiopharma-Clinical-Trial.html
https://www.globenewswire.com//news-release/2024/02/22/2833531/0/en/Monopar-Announces-Promising-Preclinical-Data-for-its-MNPR-101-Radiopharma-Program-Targeting-Advanced-Cancers.html
https://www.globenewswire.com//news-release/2024/02/20/2831765/0/en/Monopar-Receives-Clearance-to-Proceed-with-First-in-Human-Phase-1-Trial-of-Novel-Radiopharmaceutical-MNPR-101-Zr-in-Advanced-Cancers.html
https://www.globenewswire.com//news-release/2023/11/09/2777175/0/en/Monopar-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Developments.html
https://www.globenewswire.com//news-release/2023/11/01/2770950/0/en/Monopar-Presents-Data-Showing-Tumor-Reduction-Benefit-of-Camsirubicin-from-Ongoing-Phase-1b-at-the-2023-Connective-Tissue-Oncology-Society-CTOS-Annual-Meeting.html